EGFR and neoplasm: Indeed, a diversity of other tumor-associated cells can acquire or promote oncogenic phenotypes following ERBB signaling dysregulation in cancer (Schumacher et al, 2017; Wu et al, 2021; Zhang et al, 2016; Kerneur et al, 2022).